| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epigenesis, Genetic | 37 | 2025 | 771 | 6.540 |
Why?
|
| DNA Methylation | 48 | 2025 | 1093 | 6.340 |
Why?
|
| Hypothalamus | 6 | 2022 | 205 | 1.950 |
Why?
|
| CpG Islands | 19 | 2024 | 341 | 1.850 |
Why?
|
| Alleles | 10 | 2025 | 1713 | 1.700 |
Why?
|
| Motor Activity | 4 | 2016 | 507 | 1.180 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 2 | 2022 | 41 | 1.140 |
Why?
|
| Obesity | 13 | 2022 | 2392 | 1.120 |
Why?
|
| DNA Transposable Elements | 3 | 2023 | 182 | 1.100 |
Why?
|
| Physical Conditioning, Animal | 2 | 2019 | 86 | 1.040 |
Why?
|
| Gene Expression Regulation | 9 | 2023 | 2357 | 1.010 |
Why?
|
| Genomic Imprinting | 7 | 2015 | 127 | 1.000 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2013 | 232 | 0.970 |
Why?
|
| Whole Genome Sequencing | 2 | 2025 | 360 | 0.750 |
Why?
|
| Diet | 7 | 2013 | 1118 | 0.750 |
Why?
|
| Mice | 29 | 2025 | 18504 | 0.730 |
Why?
|
| Sequence Analysis, DNA | 9 | 2016 | 1746 | 0.720 |
Why?
|
| Dietary Supplements | 6 | 2008 | 454 | 0.690 |
Why?
|
| Animals | 41 | 2025 | 34460 | 0.690 |
Why?
|
| Cells | 1 | 2020 | 20 | 0.650 |
Why?
|
| Epigenomics | 5 | 2022 | 186 | 0.650 |
Why?
|
| Child Nutrition Disorders | 1 | 2020 | 41 | 0.640 |
Why?
|
| Genetic Variation | 7 | 2024 | 1566 | 0.630 |
Why?
|
| Environment | 8 | 2016 | 149 | 0.620 |
Why?
|
| Animals, Newborn | 5 | 2013 | 1023 | 0.620 |
Why?
|
| Energy Metabolism | 3 | 2015 | 786 | 0.590 |
Why?
|
| Neurons | 3 | 2019 | 1998 | 0.590 |
Why?
|
| Schizophrenia | 1 | 2021 | 332 | 0.560 |
Why?
|
| Malnutrition | 1 | 2020 | 156 | 0.560 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2004 | 85 | 0.540 |
Why?
|
| Computational Biology | 2 | 2020 | 872 | 0.500 |
Why?
|
| Genome, Human | 4 | 2019 | 1338 | 0.500 |
Why?
|
| Genome | 2 | 2015 | 473 | 0.470 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2016 | 81 | 0.470 |
Why?
|
| Maternal Behavior | 1 | 2016 | 70 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2015 | 11 | 0.460 |
Why?
|
| Disease Susceptibility | 3 | 2010 | 283 | 0.460 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2015 | 202 | 0.460 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2015 | 1005 | 0.450 |
Why?
|
| Pregnancy | 17 | 2020 | 7577 | 0.450 |
Why?
|
| Software | 1 | 2020 | 756 | 0.450 |
Why?
|
| Eating | 3 | 2014 | 382 | 0.430 |
Why?
|
| Female | 40 | 2025 | 71316 | 0.430 |
Why?
|
| Agouti Signaling Protein | 4 | 2009 | 5 | 0.430 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 3 | 2014 | 49 | 0.420 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2013 | 44 | 0.410 |
Why?
|
| Gambia | 5 | 2019 | 26 | 0.410 |
Why?
|
| Disease | 2 | 2019 | 125 | 0.400 |
Why?
|
| Neuroglia | 1 | 2015 | 223 | 0.400 |
Why?
|
| Genetic Loci | 2 | 2015 | 359 | 0.400 |
Why?
|
| Chronic Disease | 4 | 2016 | 1239 | 0.390 |
Why?
|
| Sequence Alignment | 1 | 2014 | 596 | 0.370 |
Why?
|
| Male | 31 | 2025 | 65357 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 4762 | 0.370 |
Why?
|
| Humans | 48 | 2024 | 131967 | 0.360 |
Why?
|
| Sulfites | 5 | 2015 | 27 | 0.360 |
Why?
|
| Energy Intake | 1 | 2014 | 502 | 0.350 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 260 | 0.340 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2005 | 172 | 0.330 |
Why?
|
| Aging | 3 | 2016 | 1269 | 0.330 |
Why?
|
| Gene Expression | 4 | 2020 | 1503 | 0.330 |
Why?
|
| Hair Color | 2 | 2007 | 12 | 0.330 |
Why?
|
| Genetics, Medical | 1 | 2010 | 119 | 0.310 |
Why?
|
| Body Weight | 6 | 2016 | 990 | 0.310 |
Why?
|
| Seasons | 3 | 2019 | 333 | 0.300 |
Why?
|
| Models, Biological | 1 | 2014 | 1396 | 0.300 |
Why?
|
| DNA | 6 | 2018 | 1440 | 0.290 |
Why?
|
| Embryonic Development | 2 | 2018 | 224 | 0.280 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2016 | 1008 | 0.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 934 | 0.280 |
Why?
|
| Colitis | 1 | 2010 | 159 | 0.280 |
Why?
|
| Nutrigenomics | 1 | 2008 | 7 | 0.280 |
Why?
|
| Methionine | 2 | 2013 | 97 | 0.260 |
Why?
|
| Colon | 1 | 2010 | 361 | 0.260 |
Why?
|
| Human Development | 1 | 2007 | 6 | 0.260 |
Why?
|
| Nutritional Requirements | 1 | 2008 | 160 | 0.260 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 5 | 2019 | 156 | 0.250 |
Why?
|
| Machine Learning | 2 | 2021 | 375 | 0.250 |
Why?
|
| Algorithms | 1 | 2014 | 1686 | 0.250 |
Why?
|
| Intestinal Mucosa | 2 | 2015 | 765 | 0.240 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2006 | 38 | 0.240 |
Why?
|
| Genes, Intracisternal A-Particle | 1 | 2025 | 4 | 0.230 |
Why?
|
| Behavior, Animal | 2 | 2019 | 510 | 0.230 |
Why?
|
| Adiposity | 2 | 2019 | 207 | 0.230 |
Why?
|
| Case-Control Studies | 4 | 2021 | 3453 | 0.220 |
Why?
|
| Repressor Proteins | 3 | 2014 | 781 | 0.220 |
Why?
|
| Overnutrition | 2 | 2015 | 11 | 0.210 |
Why?
|
| Gastrointestinal Tract | 1 | 2006 | 225 | 0.210 |
Why?
|
| Twins, Monozygotic | 2 | 2018 | 125 | 0.210 |
Why?
|
| Liver | 4 | 2018 | 1802 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2014 | 114 | 0.210 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2005 | 157 | 0.200 |
Why?
|
| Quantitative Trait Loci | 2 | 2023 | 307 | 0.200 |
Why?
|
| Child Development | 2 | 2020 | 274 | 0.200 |
Why?
|
| Cattle | 1 | 2024 | 521 | 0.200 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 1840 | 0.200 |
Why?
|
| Organ Specificity | 3 | 2020 | 400 | 0.190 |
Why?
|
| Health Status | 1 | 2005 | 388 | 0.190 |
Why?
|
| Fertilization | 2 | 2014 | 45 | 0.190 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2002 | 63 | 0.180 |
Why?
|
| Carcinogenesis | 2 | 2014 | 357 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 1219 | 0.180 |
Why?
|
| Random Allocation | 3 | 2007 | 423 | 0.180 |
Why?
|
| Islets of Langerhans | 1 | 2002 | 160 | 0.170 |
Why?
|
| Adult | 9 | 2020 | 31734 | 0.170 |
Why?
|
| Alkanesulfonic Acids | 1 | 2020 | 14 | 0.170 |
Why?
|
| Biomarkers | 3 | 2016 | 3415 | 0.170 |
Why?
|
| Dried Blood Spot Testing | 2 | 2020 | 31 | 0.160 |
Why?
|
| Fluorocarbons | 1 | 2020 | 69 | 0.160 |
Why?
|
| Feeding Behavior | 3 | 2015 | 724 | 0.160 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2019 | 25 | 0.160 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2019 | 21 | 0.150 |
Why?
|
| Rural Population | 2 | 2013 | 260 | 0.150 |
Why?
|
| Patched-1 Receptor | 1 | 2019 | 38 | 0.150 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 20 | 0.150 |
Why?
|
| Integrases | 2 | 2019 | 158 | 0.150 |
Why?
|
| Body Height | 1 | 2020 | 196 | 0.150 |
Why?
|
| Pituitary Gland | 1 | 2019 | 79 | 0.150 |
Why?
|
| Metabolism | 1 | 1999 | 45 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 2019 | 99 | 0.140 |
Why?
|
| Fertilization in Vitro | 2 | 2018 | 160 | 0.140 |
Why?
|
| Receptor, IGF Type 2 | 3 | 2003 | 8 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2018 | 2863 | 0.140 |
Why?
|
| Betaine | 3 | 2013 | 19 | 0.140 |
Why?
|
| Sucking Behavior | 1 | 1998 | 21 | 0.140 |
Why?
|
| Bottle Feeding | 1 | 1998 | 39 | 0.140 |
Why?
|
| Choline | 3 | 2013 | 51 | 0.140 |
Why?
|
| Vitamin B 12 | 3 | 2013 | 59 | 0.130 |
Why?
|
| Glucose | 1 | 2002 | 850 | 0.130 |
Why?
|
| Brain | 2 | 2020 | 3247 | 0.130 |
Why?
|
| Human Activities | 1 | 2016 | 7 | 0.130 |
Why?
|
| Insulin | 1 | 2002 | 1154 | 0.130 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 2016 | 1 | 0.130 |
Why?
|
| Conservation of Natural Resources | 1 | 2016 | 26 | 0.130 |
Why?
|
| Gene-Environment Interaction | 1 | 2017 | 129 | 0.130 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 67 | 0.130 |
Why?
|
| Maternal Exposure | 2 | 2009 | 149 | 0.120 |
Why?
|
| Middle Aged | 6 | 2019 | 28911 | 0.120 |
Why?
|
| Research | 2 | 2014 | 269 | 0.120 |
Why?
|
| Housing, Animal | 1 | 2016 | 19 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2022 | 1695 | 0.120 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 450 | 0.120 |
Why?
|
| Embryo Transfer | 1 | 2016 | 53 | 0.120 |
Why?
|
| Carbon | 1 | 2016 | 94 | 0.120 |
Why?
|
| Models, Genetic | 3 | 2018 | 752 | 0.120 |
Why?
|
| Child | 6 | 2020 | 26332 | 0.120 |
Why?
|
| Mice, Inbred C3H | 2 | 2007 | 108 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2019 | 3864 | 0.120 |
Why?
|
| Folic Acid | 3 | 2013 | 288 | 0.120 |
Why?
|
| Myocardium | 2 | 2019 | 876 | 0.110 |
Why?
|
| Infertility | 1 | 2016 | 79 | 0.110 |
Why?
|
| Hypogonadism | 1 | 2019 | 323 | 0.110 |
Why?
|
| Models, Animal | 3 | 2016 | 460 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 359 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2011 | 547 | 0.110 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 160 | 0.110 |
Why?
|
| Food Preferences | 1 | 2015 | 114 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2017 | 291 | 0.110 |
Why?
|
| Neonatal Screening | 1 | 2016 | 195 | 0.110 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 34 | 0.100 |
Why?
|
| Prostate | 2 | 2007 | 415 | 0.100 |
Why?
|
| Hyperphagia | 1 | 2014 | 46 | 0.100 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 417 | 0.100 |
Why?
|
| Prader-Willi Syndrome | 1 | 2014 | 62 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2007 | 611 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 203 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 657 | 0.090 |
Why?
|
| Mutation | 4 | 2014 | 6200 | 0.090 |
Why?
|
| Sex Factors | 1 | 2016 | 1352 | 0.090 |
Why?
|
| Aged | 3 | 2020 | 21279 | 0.090 |
Why?
|
| DNA Primers | 2 | 2010 | 609 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 1489 | 0.090 |
Why?
|
| Embryonic and Fetal Development | 2 | 2004 | 126 | 0.090 |
Why?
|
| Acinetobacter | 1 | 2011 | 9 | 0.090 |
Why?
|
| S-Adenosylhomocysteine | 2 | 2013 | 16 | 0.090 |
Why?
|
| S-Adenosylmethionine | 2 | 2013 | 27 | 0.090 |
Why?
|
| Intestines | 1 | 2015 | 592 | 0.090 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2011 | 35 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1069 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2013 | 300 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2020 | 5122 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 2368 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1951 | 0.080 |
Why?
|
| Cytosine | 2 | 2010 | 58 | 0.080 |
Why?
|
| Stem Cells | 1 | 2015 | 713 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 4684 | 0.080 |
Why?
|
| Child Welfare | 1 | 2010 | 68 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2019 | 4693 | 0.080 |
Why?
|
| Phenotype | 4 | 2014 | 4531 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 226 | 0.080 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2009 | 79 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2020 | 8604 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2011 | 231 | 0.070 |
Why?
|
| Mice, Obese | 1 | 2008 | 73 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2008 | 1398 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2006 | 334 | 0.070 |
Why?
|
| Carcinogens, Environmental | 1 | 2007 | 12 | 0.070 |
Why?
|
| Introns | 2 | 2006 | 288 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2008 | 228 | 0.070 |
Why?
|
| Cadmium | 1 | 2007 | 33 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1236 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 3616 | 0.070 |
Why?
|
| Infant | 4 | 2010 | 13332 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2008 | 121 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 893 | 0.060 |
Why?
|
| Neoplasms | 3 | 2018 | 2965 | 0.060 |
Why?
|
| Lactation | 1 | 2008 | 197 | 0.060 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2015 | 25 | 0.060 |
Why?
|
| Axin Protein | 1 | 2006 | 18 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2018 | 15066 | 0.060 |
Why?
|
| Heterozygote | 2 | 2006 | 728 | 0.060 |
Why?
|
| Age Factors | 2 | 2010 | 2869 | 0.060 |
Why?
|
| Genistein | 1 | 2006 | 39 | 0.060 |
Why?
|
| Fundulidae | 1 | 2005 | 1 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 155 | 0.060 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2006 | 85 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 297 | 0.060 |
Why?
|
| Genomics | 1 | 2014 | 1630 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 3425 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 375 | 0.060 |
Why?
|
| Sodium Compounds | 1 | 2005 | 9 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2005 | 82 | 0.060 |
Why?
|
| Arsenites | 1 | 2005 | 19 | 0.060 |
Why?
|
| Infant Care | 1 | 2005 | 46 | 0.060 |
Why?
|
| Base Sequence | 4 | 2015 | 2783 | 0.060 |
Why?
|
| Genes, ras | 1 | 2005 | 99 | 0.050 |
Why?
|
| Genotype | 2 | 2008 | 2655 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2007 | 900 | 0.050 |
Why?
|
| Histones | 3 | 2015 | 537 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 1841 | 0.050 |
Why?
|
| Exons | 2 | 2003 | 769 | 0.050 |
Why?
|
| Pedigree | 1 | 2007 | 1714 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2005 | 227 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2003 | 101 | 0.050 |
Why?
|
| Asthma | 1 | 2011 | 927 | 0.050 |
Why?
|
| Testis | 2 | 2019 | 413 | 0.050 |
Why?
|
| Litter Size | 1 | 2002 | 24 | 0.050 |
Why?
|
| Ovary | 2 | 2019 | 361 | 0.050 |
Why?
|
| Weaning | 1 | 2002 | 52 | 0.050 |
Why?
|
| Kidney | 2 | 2006 | 1304 | 0.040 |
Why?
|
| Cell Line | 3 | 2013 | 2607 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2002 | 200 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2002 | 309 | 0.040 |
Why?
|
| Adolescent | 4 | 2015 | 21008 | 0.040 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2020 | 9 | 0.040 |
Why?
|
| Caprylates | 1 | 2020 | 19 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2020 | 23 | 0.040 |
Why?
|
| Point Mutation | 1 | 2002 | 339 | 0.040 |
Why?
|
| Pancreas | 1 | 2002 | 218 | 0.040 |
Why?
|
| Young Adult | 2 | 2013 | 10108 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2019 | 18 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2019 | 52 | 0.040 |
Why?
|
| Lymphocytes | 2 | 2014 | 359 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2019 | 46 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2992 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 1999 | 95 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 66 | 0.040 |
Why?
|
| Infant Behavior | 1 | 1998 | 16 | 0.030 |
Why?
|
| Viscosity | 1 | 1998 | 39 | 0.030 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 46 | 0.030 |
Why?
|
| Infant Food | 1 | 1998 | 73 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2007 | 3708 | 0.030 |
Why?
|
| Pressure | 1 | 1998 | 126 | 0.030 |
Why?
|
| Reproduction | 1 | 2019 | 217 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2002 | 1104 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 974 | 0.030 |
Why?
|
| DNA Replication | 1 | 1999 | 359 | 0.030 |
Why?
|
| Insemination, Artificial | 1 | 2016 | 11 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2018 | 287 | 0.030 |
Why?
|
| Body Composition | 1 | 1999 | 550 | 0.030 |
Why?
|
| Equipment Design | 1 | 1998 | 557 | 0.030 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2016 | 50 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2963 | 0.030 |
Why?
|
| Animals, Suckling | 1 | 2015 | 52 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 3462 | 0.030 |
Why?
|
| Body Patterning | 1 | 2016 | 128 | 0.030 |
Why?
|
| Time Factors | 1 | 2006 | 6285 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 1204 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 546 | 0.030 |
Why?
|
| Program Development | 1 | 2016 | 181 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2015 | 102 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 121 | 0.030 |
Why?
|
| Hair Follicle | 1 | 2014 | 33 | 0.030 |
Why?
|
| Satiety Response | 1 | 2014 | 31 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 266 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 692 | 0.030 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 59 | 0.030 |
Why?
|
| Testosterone | 1 | 2019 | 604 | 0.030 |
Why?
|
| Vitamin B 6 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Sarcosine | 1 | 2013 | 8 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2015 | 234 | 0.020 |
Why?
|
| CCCTC-Binding Factor | 1 | 2013 | 14 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 274 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2015 | 347 | 0.020 |
Why?
|
| Riboflavin | 1 | 2013 | 31 | 0.020 |
Why?
|
| Diet Records | 1 | 2013 | 70 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2002 | 1001 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 201 | 0.020 |
Why?
|
| Homocysteine | 1 | 2013 | 118 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 108 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 140 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 390 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2013 | 125 | 0.020 |
Why?
|
| Life Style | 1 | 2015 | 445 | 0.020 |
Why?
|
| Research Design | 1 | 2016 | 723 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 495 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2013 | 276 | 0.020 |
Why?
|
| RNA | 1 | 2015 | 530 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 1394 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2013 | 217 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 695 | 0.020 |
Why?
|
| Japan | 2 | 2002 | 174 | 0.020 |
Why?
|
| Acetylation | 1 | 2011 | 181 | 0.020 |
Why?
|
| Sex Differentiation | 1 | 2010 | 18 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1236 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 248 | 0.020 |
Why?
|
| Risk Factors | 2 | 2017 | 10998 | 0.020 |
Why?
|
| Microbiota | 1 | 2015 | 444 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 579 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 3708 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2016 | 558 | 0.020 |
Why?
|
| Exercise | 1 | 2015 | 866 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1020 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 233 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2007 | 59 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 80 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 230 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2008 | 250 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 495 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 664 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2008 | 259 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 832 | 0.010 |
Why?
|
| DNA Modification Methylases | 1 | 2005 | 46 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 293 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 139 | 0.010 |
Why?
|
| Fetal Viability | 1 | 2003 | 29 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2003 | 76 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 803 | 0.010 |
Why?
|
| Fetus | 1 | 2006 | 585 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1790 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 2002 | 42 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 6522 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2003 | 171 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2002 | 124 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 257 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 339 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 13011 | 0.010 |
Why?
|
| Artifacts | 1 | 2001 | 110 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 2013 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 1964 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2001 | 750 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1610 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 1004 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 1571 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 6922 | 0.010 |
Why?
|
| United States | 1 | 2001 | 11827 | 0.000 |
Why?
|